# Jasper Therapeutics, Inc.: Form S-1, filed Oct 18, 2021

- Company: [Jasper Therapeutics, Inc.](/companies/jspr.md) (CIK 1788028)
- Form: S-1
- Filed: 2021-10-18
- Accepted by EDGAR: Oct 15, 2021, 18:08 ET
- Period: not reported
- Accession: 0001213900-21-053099
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1788028/000121390021053099/fs12021_jaspertherap.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1788028/000121390021053099/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1788028/000121390021053099/fs12021_jaspertherap.htm

Filed Oct 18, 2021.
Source: SEC EDGAR, the filing index for accession 0001213900-21-053099. Last ingested by Listed: Nov 14, 2026, 21:17 ET. No prices; not investment advice.
